Answers are grounded in this paper and cite their sources.
These results demonstrate that PGRN promotes M2 polarization and PD-L1 expression by activating the STAT3 signaling pathway. Furthermore, through PD-1/PD-L1 interaction, PGRN can promote the breast tumor immune escape. Our research may provide new ideas and targets for clinical breast cancer immunotherapy.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: